LHC Group, Inc. (LHCG) Position Decreased by Oberweis Asset Management Inc.
Oberweis Asset Management Inc. lowered its stake in shares of LHC Group, Inc. (NASDAQ:LHCG) by 8.6% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 88,983 shares of the health services provider’s stock after selling 8,400 shares during the period. LHC Group makes up approximately 1.9% of Oberweis Asset Management Inc.’s investment portfolio, making the stock its 8th largest position. Oberweis Asset Management Inc. owned 0.28% of LHC Group worth $8,354,000 at the end of the most recent reporting period.
Several other large investors also recently bought and sold shares of LHCG. Kiwi Wealth Investments Limited Partnership lifted its position in shares of LHC Group by 51.7% during the 4th quarter. Kiwi Wealth Investments Limited Partnership now owns 35,842 shares of the health services provider’s stock worth $3,365,000 after purchasing an additional 12,220 shares during the last quarter. Geode Capital Management LLC lifted its position in shares of LHC Group by 6.7% during the 4th quarter. Geode Capital Management LLC now owns 325,548 shares of the health services provider’s stock worth $30,562,000 after purchasing an additional 20,482 shares during the last quarter. Magnus Financial Group LLC purchased a new stake in shares of LHC Group during the 4th quarter worth $282,000. California State Teachers Retirement System lifted its position in shares of LHC Group by 2.9% during the 4th quarter. California State Teachers Retirement System now owns 46,427 shares of the health services provider’s stock worth $4,359,000 after purchasing an additional 1,318 shares during the last quarter. Finally, United Services Automobile Association lifted its position in shares of LHC Group by 4.9% during the 4th quarter. United Services Automobile Association now owns 6,955 shares of the health services provider’s stock worth $653,000 after purchasing an additional 323 shares during the last quarter. 91.72% of the stock is owned by hedge funds and other institutional investors.
LHCG has been the subject of several recent analyst reports. Barclays initiated coverage on shares of LHC Group in a research report on Friday, December 14th. They set an “equal weight” rating and a $105.00 price objective for the company. UBS Group initiated coverage on shares of LHC Group in a research report on Thursday, November 15th. They set a “buy” rating and a $109.00 price objective for the company. SunTrust Banks lifted their price objective on shares of LHC Group to $130.00 and gave the stock a “buy” rating in a research report on Friday, March 1st. Robert W. Baird lifted their price target on shares of LHC Group from $98.00 to $120.00 and gave the stock a “neutral” rating in a research note on Monday, March 4th. Finally, Craig Hallum lifted their price target on shares of LHC Group from $93.00 to $114.00 and gave the stock a “hold” rating in a research note on Friday, March 1st. They noted that the move was a valuation call. Four investment analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company. LHC Group has an average rating of “Buy” and an average target price of $113.33.
LHC Group (NASDAQ:LHCG) last posted its quarterly earnings data on Wednesday, February 27th. The health services provider reported $1.03 EPS for the quarter, beating analysts’ consensus estimates of $1.02 by $0.01. The company had revenue of $509.80 million for the quarter, compared to analyst estimates of $522.21 million. LHC Group had a net margin of 3.50% and a return on equity of 8.40%. LHC Group’s quarterly revenue was up 75.1% on a year-over-year basis. During the same period in the previous year, the business posted $0.62 earnings per share. Research analysts predict that LHC Group, Inc. will post 4.2 earnings per share for the current year.
In other news, EVP Joshua L. Proffitt sold 11,003 shares of LHC Group stock in a transaction dated Monday, March 11th. The shares were sold at an average price of $107.36, for a total value of $1,181,282.08. Following the sale, the executive vice president now owns 66,980 shares of the company’s stock, valued at $7,190,972.80. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, CEO Keith G. Myers sold 75,000 shares of LHC Group stock in a transaction dated Friday, March 1st. The shares were sold at an average price of $108.53, for a total transaction of $8,139,750.00. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 257,944 shares of company stock worth $26,570,216. 6.80% of the stock is currently owned by company insiders.
ILLEGAL ACTIVITY NOTICE: This report was originally posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this report on another site, it was illegally copied and republished in violation of United States and international copyright and trademark laws. The original version of this report can be viewed at https://www.thecerbatgem.com/2019/03/15/lhc-group-inc-lhcg-position-decreased-by-oberweis-asset-management-inc.html.
LHC Group Profile
LHC Group, Inc provides post-acute health care services to patients through its home nursing agencies, hospices and long-term acute care hospitals. The company operates through the following business segments: Home Health Services, Hospice Services, Community-Based Services and Facility-Based Services.
Featured Story: How are the companies in the S&P 500 selected?
Want to see what other hedge funds are holding LHCG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for LHC Group, Inc. (NASDAQ:LHCG).
Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.